Korea Otsuka International Asia Arab clinical trials

A country office of Otsuka Holdings Co., Ltd.

The registry lists 2 studies whose lead sponsor is Korea Otsuka International Asia Arab. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 31, 2022.

Status

Completed: 2

Phase

Phase 4: 2

Where

Taiwan: 1
Hong Kong: 1
Philippines: 1
China: 1
Korea, Republic of: 1
Thailand: 1

Registry sponsor names on this page

Korea Otsuka International Asia Arab2 studies

Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Otsuka Holdings Co., Ltd. studies →

ABLE: Abilify in Bipolar Disorder for Long-term EffectivenessCompletedNCT00484471Phase 4
Sponsor listed in the registry: Korea Otsuka International Asia Arab
Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication TherapyCompletedNCT00272467Phase 4
Sponsor listed in the registry: Korea Otsuka International Asia Arab